EDAP TMS S.A. (EDAP)

6,88 -0,01 (-0,15%) Al cierre: 04:00PM EDT

EDAP TMS S.A.

Parc dActivites la Poudrette-Lamartine
4/6, rue du DauphinE Vaulx-en-Velin
Lyon 69120
France
33 4 72 153 150
https://www.edap-tms.com

Sector(es): Healthcare
Sector: Medical Distribution
Empleados a tiempo completo: 307

Ejecutivos clave

Nombre	Título	Paga	Ejecutado	Año de nacimiento
Mr. Marc Oczachowski	Executive Chairman	N/A	N/A	1970
Mr. Ryan Rhodes	CEO & Director	N/A	N/A	1962
Mr. Ken Mobeck	Chief Financial Officer	N/A	N/A	1971
Mr. Carre Emmanuel	Chief Operating Officer	N/A	N/A	N/A
Mr. Francois Dietsch	Chief Accounting Officer	N/A	N/A	1976
Ms. Blandine Confort	Head of Legal Affairs & Investor Relations and Secretary	N/A	N/A	N/A
Mr. Frederic Pech	President of EDAP TMS France	N/A	N/A	1969
Mr. Jean-Francois Bachelard	President & Chief Executive Officer of Edaptechnomed Co. Ltd.	N/A	N/A	1964

Los importes son a partir de y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Paga es el salario, las bonificaciones, etc. Ejecutado es el valor de las opciones ejecutadas durante el año fiscal. Divisa en USD.

Descripción

EDAP TMS S.A., together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. The company operates through High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST) segments. The HIFU segment develops, manufactures, and markets medical devices based on HIFU technology for the minimally invasive treatment of urological and other clinical indications. This segment also offers Ablatherm, an ultrasound guided robotic HIFU device for the treatment of organ-confined prostate cancer; and the Focal One, a HIFU robotic device dedicated to the focal therapy of prostate cancer, as well as disposables, and leasing and treatment related services; and maintenance services. The ESWL division manufactures, markets, and services lithotripter for the treatment of urinary tract stones by means of ESWL technology; and offers Sonolith i-move, an extracorporeal shockwave lithotripter, as well as sells disposable parts for lithotripters and electrodes. The Distribution division markets, distributes, and services lasers, micro-ultrasound systems, and other medical products from third parties, as well as leases devices; sells disposables and spare parts; and offers maintenance services. It markets and sells its products through its direct marketing, sales organization, and service platform, as well as through third-party distributors and agents. The company serves hospitals, urology clinics, and research institutions. EDAP TMS S.A. was incorporated in 1979 and is based in Lyon, France.

Gobierno corporativo

El ISS Governance QualityScore de EDAP TMS S.A., a día N/A, es N/A. Las puntuaciones base son Auditoría: N/A; Tablero: N/A; Derechos de los accionistas: N/A; Compensación: N/A.

Puntuación de gobierno corporativo cedida por Institutional Shareholder Services (ISS). Las puntuaciones indican un rango decil relativo al índice o región. Una puntuación decil de 1 indica un menor riesgo de gobierno, mientras que un 10 indica un riesgo de gobierno superior.